Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
15.48
-0.14 (-0.90%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Sotera Health Company Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SHC stock have an average target of 15.7, with a low estimate of 13 and a high estimate of 17. The average target predicts an increase of 1.42% from the current stock price of 15.48.
Analyst Consensus: Buy
* Price targets were last updated on Aug 6, 2024.
Analyst Ratings
The average analyst rating for SHC stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +9.82% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +9.82% | Aug 6, 2024 |
| Piper Sandler | Piper Sandler | Hold Initiates $13 | Hold | Initiates | $13 | -16.02% | May 21, 2024 |
| Barclays | Barclays | Buy Maintains $19 → $14 | Buy | Maintains | $19 → $14 | -9.56% | Apr 10, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $18 → $16 | Hold → Strong Buy | Upgrades | $18 → $16 | +3.36% | Apr 3, 2024 |
Financial Forecast
Revenue This Year
1.12B
from 1.05B
Increased by 6.36%
Revenue Next Year
1.20B
from 1.12B
Increased by 7.80%
EPS This Year
0.73
from 0.18
Increased by 306.53%
EPS Next Year
0.84
from 0.73
Increased by 15.36%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.2B | 1.3B | 1.3B | ||
| Avg | 1.1B | 1.2B | 1.3B | ||
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.8% | 20.1% | 11.5% | ||
| Avg | 6.4% | 7.8% | 6.5% | ||
| Low | 2.8% | 3.0% | 2.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.77 | 0.92 | 1.05 |
| Avg | 0.73 | 0.84 | 0.99 |
| Low | 0.71 | 0.79 | 0.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 325.8% | 26.1% | 24.4% |
| Avg | 306.5% | 15.4% | 16.7% |
| Low | 292.0% | 8.5% | 10.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.